Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers Meeting Abstract
| Authors: | Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; Drilon, A. |
| Abstract Title: | Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | kras; synthetic lethal |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S663 |
| Language: | English |
| ACCESSION: | WOS:000370365103221 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30012-0 |
| Notes: | Meeting Abstract: P3.01-075 -- Source: Wos |
